Yup, I'm hoping MSB can replicate these findings!
We need more tools for CLBP.
I've got a decent amount of experience managing this patient population and many are desperate to get it sorted.
Hopefully MSB can add another tool to our arsenal. But anyone here who actually has experience managing CLBP would understand my reservations - it's a complex multi factorial issue with a strong psychosocial component.
And when you've got this subjective decrease in pain, yet no increase in function, it should make you a bit suspicious.
Anyways I won't go on anymore about this topicif you are interested in learning about inflammation, I suggest you start with Robbins pathology, and keep away from google.
How low can we go?, page-79
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |